NCT04568707已完成不适用
Evaluation of Biological Response to SARS-COV2 in Patients With Pre-existing Neurological Disease or With New Neurological Manifestations of COVID-19
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 238
- 试验地点
- 2
- 主要终点
- dosage of seric markers (anti-SARS-CoV2 IgG) or genetic markers (genetic variants) observed during COVID 19 infection in patients
研究概览
简要总结
Patients with neurological or psychiatric symptoms or pre-existing disease will be sampled (blood for serum and DNA or saliva for DNA) at inclusion and at M6 (blood) and M12 (blood) depending on their pathology. Sampling will be done either at hospital if patient is on site for routine care or at home if no consultation is scheduled at hospital.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
dosage of seric markers (anti-SARS-CoV2 IgG) or genetic markers (genetic variants) observed during COVID 19 infection in patients
时间窗: 12 months
dosage of seric markers (anti-SARS-CoV2 IgG) or genetic markers (genetic variants) observed during COVID 19 infection in patients
次要结局
- Serum neurofilaments(12 months)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
COVID-19 in Patients With Anosmia in EgyptCovid19DysgeusiaAnosmiaNCT04473157Ain Shams University58
已完成
不适用
Nervous System Symptoms Associated With COVID 19Covid19NCT04922905University Hospital, Toulouse99
尚未招募
不适用
Collection of Additional Biological Samples From Potentially COVID-19 Patients for Monitoring of Biological Parameters Carried Out as Part of the RoutineSARS CoV 2 InfectionNCT06144333CerbaXpert7,500
招募中
不适用
A Follow-up Study of Immune Dysregulation in Patients With COVID-19COVID-19ImmunosuppressionNCT05669248Qilu Hospital of Shandong University200
已完成
不适用
COVID-19 Search in Conjunctival CellsCOVID 19Pulmonary DiseaseNCT04364594Fondazione Policlinico Universitario Agostino Gemelli IRCCS50